Tetralogy of Fallot

Tetralogy of Fallot
Mariana Ruiz LadyofHats · Public domain · source
Name	Tetralogy of Fallot
Caption	Schematic representation of conotruncal malformations
Field	Pediatric cardiology
Onset	Congenital
Causes	Developmental malformation of the cardiac outflow tract
Treatment	Surgical repair, medical management
Frequency	Approximately 1 in 2,000 live births

Tetralogy of Fallot is a congenital cardiac malformation featuring four anatomical abnormalities that produce right‑to‑left shunting and cyanosis. First characterized in the 19th century and refined by 20th‑century surgeons and pathologists, the condition remains a principal subject in pediatric cardiology, pediatric surgery, and medical genetics. It is encountered worldwide across diverse clinical settings from tertiary centers associated with institutions such as Boston Children's Hospital and Great Ormond Street Hospital to regional referral hospitals in countries represented by United Kingdom, United States, India, and Brazil.

Background and epidemiology

The lesion was described during the era of anatomical pioneers linked to names like Étienne-Louis Malgaigne and later anatomists in the tradition of Rudolf Virchow and Sir William Osler, and its surgical correction became possible following advances associated with teams at Johns Hopkins Hospital and Hospital for Sick Children, Toronto. Contemporary epidemiology derives from registries maintained by organizations such as World Health Organization, Centers for Disease Control and Prevention, European Congenital Heart Disease Network, and national birth defect surveillance programs in Sweden, Denmark, and Japan. Incidence estimates approximate 3–5 per 10,000 live births, with variable prevalence reported by cohorts from Norway, Australia, and South Africa. Associations with chromosomal and syndromic conditions are documented in series from genetics centers including Guy's Hospital and the National Institutes of Health; notable links include syndromes studied at Great Ormond Street Hospital and genetic findings reported by groups at Broad Institute.

Pathophysiology

The anatomical quartet comprises ventricular septal defect, pulmonary infundibular stenosis, overriding aorta, and right ventricular hypertrophy, described in classical pathology collections at institutions like Mayo Clinic and Royal Brompton Hospital. Embryologic models developed by laboratories affiliated with Cambridge University and Harvard Medical School implicate abnormal conal septation and neural crest cell migration studied in experimental systems at Max Planck Society and Karolinska Institute. Hemodynamic consequences—right‑to‑left shunting, hypoxemia, and compensatory erythrocytosis—have been elaborated in publications from American Heart Association, European Society of Cardiology, and surgical series from Cleveland Clinic. Concomitant lesions documented in case series from Mount Sinai Hospital and St Thomas' Hospital include pulmonary atresia and major aorto‑pulmonary collateral arteries, with genetic modifiers reported by consortia including researchers at Wellcome Trust and Cold Spring Harbor Laboratory.

Clinical presentation and diagnosis

Presentation ranges from neonatal cyanosis described in classic pediatric textbooks from Guy's Hospital to "tet spells" detailed in clinical reports from Boston Children's Hospital and observational cohorts from McGill University Health Centre. Physical findings and complications—clubbing, systolic murmur, syncope, and cerebrovascular events—are captured in case collections at Royal Children's Hospital, Melbourne and Texas Children's Hospital. Diagnostic strategies utilize chest radiography, electrocardiography, and echocardiography performed in echo labs at Johns Hopkins Hospital and Sheba Medical Center, with cross‑sectional imaging (cardiac MRI, CT) available from imaging centers at Mayo Clinic and Karolinska University Hospital. Fetal diagnosis via obstetric screening programs affiliated with Columbia University and genetic counseling services offered through centers such as National Health Service genetics clinics enable prenatal planning and perinatal management in collaboration with neonatal units like those at University of California, San Francisco.

Management and treatment

Initial stabilization approaches—oxygen, knee‑to‑chest positioning, and prostaglandin E1 infusion to maintain ductal patency—are outlined in emergency pediatric guidelines from American Academy of Pediatrics and perioperative protocols established at Great Ormond Street Hospital. Surgical strategies have evolved from early palliative shunts pioneered at Children's Hospital of Philadelphia and Guy's Hospital to complete intracardiac repair techniques standardized in programs at Cleveland Clinic and Boston Children's Hospital. Transcatheter interventions emerging from interventional suites at Royal Brompton Hospital and Mount Sinai Hospital include stenting of conduits and pulmonary valve procedures developed in collaboration with device makers and regulatory agencies like Food and Drug Administration. Longitudinal care requires multidisciplinary teams integrating services at centers such as Johns Hopkins Hospital, Massachusetts General Hospital, and regional congenital heart networks administered in partnership with organizations like World Health Organization and national health ministries.

Prognosis and long-term outcomes

Outcomes have markedly improved with early surgical repair performed at tertiary centers including Great Ormond Street Hospital and Texas Children's Hospital, with survival curves reported in long‑term cohorts from Brigham and Women's Hospital and population studies in Canada and Denmark. Late complications—residual ventricular dysfunction, arrhythmias, conduit degeneration, and need for reintervention—are managed in adult congenital heart disease programs at Royal Brompton Hospital and Cleveland Clinic. Neurodevelopmental and psychosocial sequelae are addressed through multidisciplinary services analogous to those at Johns Hopkins Hospital and rehabilitation programs studied in trials funded by National Institutes of Health and philanthropic organizations like Wellcome Trust. Transition to adult care frequently involves centers affiliated with university hospitals such as University College London Hospitals and integrated registries maintained by consortia including the European Congenital Heart Surgeons Association.

Category:Congenital heart defects